Atlantic Cancer Consortium leadership and members share updates with the Network

On Thursday, October 24th, leadership and researchers from the Atlantic Cancer Consortium (ACC) presented their work to Network members as part of the MOHCCN seminar series

This series, which is being held periodically throughout the year, features virtual talks from MOHCCN leadership, investigators and trainees from each region, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. 

This event will be co-chaired by Christine Wu, a member of the MOHCCN Patient Working Group from Campbellville, ON, and Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.

Watch the full video

 

Speakers

ACC consortium activities update

  • Dr. Sherri Christian - Professor, Department of Biochemistry, Memorial University of Newfoundland; MOHCCN consortium lead (PR2C)

Biobank NL overview

  • Daniel Loos - Coordinator, Biobank NL

THSD4: a novel mediator of immune exclusion and pembrolizumab response in breast cancer